4.5 Review

Impact of Lipotoxicity on Tissue Cross Talk and Metabolic Regulation

期刊

PHYSIOLOGY
卷 34, 期 2, 页码 134-149

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physiol.00037.2018

关键词

-

资金

  1. National Health and Medical Research Council of Australia
  2. University of Melbourne

向作者/读者索取更多资源

Obesity-associated comorbidities include non-alcoholic fatty liver disease, Type 2 diabetes, and cardiovascular disease. These diseases are associated with accumulation of lipids in non-adipose tissues, which can impact many intracellular cellular signaling pathways and functions that have been broadly defined as lipotoxic. This review moves beyond understanding intracellular lipotoxic outcomes and outlines the consequences of lipotoxicity on protein secretion and inter-tissue cross talk, and the impact this exerts on systemic metabolism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Endocrinology & Metabolism

Inter-organelle Communication in the Pathogenesis of Mitochondrial Dysfunction and Insulin Resistance

Stacey N. Keenan, Matthew J. Watt, Magdalene K. Montgomery

CURRENT DIABETES REPORTS (2020)

Review Pharmacology & Pharmacy

Molecular regulators of lipid metabolism in the intestine - Underestimated therapeutic targets for obesity?

Mercedes Davalos-Salas, John M. Mariadason, Matthew J. Watt, Magdalene K. Montgomery

BIOCHEMICAL PHARMACOLOGY (2020)

Article Cell Biology

SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control

Magdalene K. Montgomery, Jacqueline Bayliss, Camille Devereux, Ayenachew Bezawork-Geleta, David Roberts, Cheng Huang, Ralf B. Schittenhelm, Andrew Ryan, Scott L. Townley, Luke A. Selth, Trevor J. Biden, Gregory R. Steinberg, Dorit Samocha-Bonet, Ruth C. R. Meex, Matthew J. Watt

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Perilipin 5 S155 phosphorylation by PKA is required for the control of hepatic lipid metabolism and glycemic control

Stacey N. Keenan, William De Nardo, Jieqiong Lou, Ralf B. Schittenhelm, Magdalene K. Montgomery, James G. Granneman, Elizabeth Hinde, Matthew J. Watt

Summary: PLIN5 is a lipid-droplet associated protein that regulates lipid metabolism through PKA phosphorylation, with phosphorylation at S155 playing a crucial role in lipid metabolism and interactions with lipases at the lipid droplet. This study highlights the importance of PLIN5 S155 in PKA-mediated lipolysis and its impact on lipid metabolism and glycemic control.

JOURNAL OF LIPID RESEARCH (2021)

Article Endocrinology & Metabolism

Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes

Jacqueline Bayliss, Geraldine J. Ooi, William De Nardo, Yazmin Johari Halim Shah, Magdalene K. Montgomery, Catriona McLean, William Kemp, Stuart K. Roberts, Wendy A. Brown, Paul R. Burton, Matthew J. Watt

Summary: The study found that plasma EDA is increased in NAFL and NASH, is related to worsening steatosis and fibrosis, but is not a reliable biomarker for NASH. Additionally, circulating EDA is not associated with insulin resistance in human obesity.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Multidisciplinary Sciences

Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control

Magdalene K. Montgomery, Jacqueline Bayliss, Shuai Nie, William De Nardo, Stacey N. Keenan, Paula M. Miotto, Hamzeh Karimkhanloo, Cheng Huang, Ralf B. Schittenhelm, Anthony S. Don, Andrew Ryan, Nicholas A. Williamson, Geraldine J. Ooi, Wendy A. Brown, Paul R. Burton, Benjamin L. Parker, Matthew J. Watt

Summary: Non-alcoholic steatohepatitis (NASH) and type 2 diabetes are closely linked, and this study identifies arylsulfatase A (ARSA) as a regulator that improves muscle insulin sensitivity and systemic glucose control by inhibiting liver secretion of lysophosphatidylcholine and lysophosphatidic acid.

NATURE COMMUNICATIONS (2022)

Article Endocrinology & Metabolism

Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism

William De Nardo, Paula M. Miotto, Jacqueline Bayliss, Shuai Nie, Stacey N. Keenan, Magdalene K. Montgomery, Matthew J. Watt

Summary: Regular exercise training can remodel hepatocyte proteome and alter metabolism in the liver and skeletal muscle. Syndecan-4 (SDC4), an exercise-responsive hepatokine, has been identified to reduce fatty acid uptake and alleviate steatosis in the liver. The findings suggest that exercise-induced changes in hepatokine secretion may hold therapeutic potential for treating NAFLD.

MOLECULAR METABOLISM (2022)

Article Endocrinology & Metabolism

Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice

Camille J. Devereux, Jacqueline Bayliss, Stacey N. Keenan, Magdalene K. Montgomery, Matthew J. Watt

Summary: The dysregulation of hepatic lipid metabolism is a characteristic feature of nonalcoholic fatty liver disease. In this study, dual inhibition of the de novo lipogenesis enzyme, ACC, and the hepatic deletion of the fatty acid transporter, CD36, was found to be ineffective for the treatment of NAFLD in mice.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2023)

Article Endocrinology & Metabolism

Liver-Secreted Hexosaminidase A Regulates Insulin-Like Growth Factor Signaling and Glucose Transport in Skeletal Muscle

Magdalene K. Montgomery, Jacqueline Bayliss, Shuai Nie, William de Nardo, Stacey N. Keenan, Marziyeh Anari, Amanuiel Z. Taddese, Nicholas A. Williamson, Geraldine J. Ooi, Wendy A. Brown, Paul R. Burton, Paul Gregorevic, Craig A. Goodman, Kevin I. Watt, Matthew J. Watt

Summary: Nonalcoholic fatty liver disease (NAFLD) and impaired glycemic control are closely linked. Hexosaminidase A (HEXA) is identified as an NAFLD-induced hepatokine that improves blood glucose control by increasing skeletal muscle glucose uptake. HEXA remodels muscle lipid raft ganglioside composition, thus increasing IGF-1 signaling and GLUT4 localization to the cell surface. This study identifies a pathway for intertissue communication between liver and skeletal muscle in the regulation of systemic glycemic control.

DIABETES (2023)

Article Oncology

Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer

Gio Fidelito, David P. De Souza, Birunthi Niranjan, William De Nardo, Shivakumar Keerthikumar, Kristin Brown, Renea A. Taylor, Matthew J. Watt

Summary: Cancer cells undergo metabolic reprogramming to meet increased bioenergetic demands. Glucose, glutamine, and fatty acid oxidation were upregulated in malignant PDXs compared with benign PDXs. Fatty acid uptake and oxidation are targetable metabolic dependencies in human prostate cancer.

MOLECULAR CANCER RESEARCH (2023)

Article Endocrinology & Metabolism

Exercise training induces depot-specific remodeling of protein secretion in skeletal muscle and adipose tissue of obese male mice

Magdalene K. Montgomery, William De Nardo, Matthew J. Watt

Summary: This study examines the effects of exercise training on protein secretion from fast-twitch and slow-twitch muscle as well as visceral and subcutaneous adipose tissue of obese mice. Although exercise training leads to substantial remodeling of protein secretion from fast-twitch muscle, adipose tissue is completely refractory to exercise regulation.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2023)

Review Pharmacology & Pharmacy

Phospholipid metabolism in the liver-Implications for phosphatidylserine in non-alcoholic fatty liver disease

Marziyeh Anari, Magdalene K. Montgomery

Summary: Mammalian cells contain a wide variety of glycerophospholipid species, with phosphatidylserine (PS) playing a crucial role in various physiological processes. PS is involved in apoptosis, blood clotting, cancer pathogenesis, and muscle and brain function. Recent studies have focused on the role of hepatic PS in non-alcoholic fatty liver disease (NAFLD) and liver cancer progression. This review provides a comprehensive overview of hepatic phospholipid metabolism and delves into the metabolism of PS in advanced liver disease.

BIOCHEMICAL PHARMACOLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

The GR-KLF15 axis promotes suppression of hepatic lipogenesis during fasting

Jie Lu, Li Dong, Magdalene K. Montgomery

Summary: Fasting induces physiological changes in peripheral tissues, such as the liver, by suppressing the expression and activity of SREBP-1 to conserve glucose for maintaining blood glucose levels. Yoshinori Takeuchi and colleagues provide insights into the regulatory mechanism of SREBP-1 expression during fasting, highlighting the importance of the hypothalamic-pituitary-adrenal axis and glucocorticoid-induced binding of the glucocorticoid receptor to enhancer regions of the KLF15 gene.

FEBS JOURNAL (2023)

暂无数据